A Grade 3 Vaccine-Related Adverse Event is Serious
When Moderna, Inc. announced on May 18, 2020 the results of a Phase 1 human clinical trial for its experimental mRNA-1273 vaccine for COVID-19, the biotechnology company said the vaccine had produced no “serious adverse events” (SAEs) among the 45 people who participated in the trial and that it considered the vaccine to be “generally […]
First COVID-19 Vaccines May Not Prevent SARS-CoV-2 Infection Says Fauci
The first generation of COVID-19 vaccines may not prevent people from becoming infected with or transmitting SARS-CoV-2 virus (COVID-19). According to Anthony Fauci, MD, director of the U.S. National Institute of Allergy and Infectious Diseases (NIAID) and other infectious disease experts, the best that COVID-19 vaccines may do is prevent people becoming severely ill and […]
Children Recruited in U.K. for COVID-19 Vaccine Trial
The University of Oxford’s Jenner Institute and Oxford Vaccine Group in the United Kingdom has announced that its researchers have begun recruiting children aged five to 12 years for phase II and phase III clinical trials testing an experimental COVID-19 vaccine the university is developing in partnership with AstraZeneca plc.1 Oxford’s ChAdOx1 nCov-19 (“chimpanzee adenovirus […]
Oxford Begins COVID-19 Vaccine Trials to Meet September Deadline
On Mar. 17, 2020, European Commission (EC) president Ursula von der Leyen said she was hopeful a vaccine for COVID-19 could be available this September. Her view was based on conversations she had had with managers of German biotechnology firm CureVac AG which has developed an experimental messenger RNA (mRNA) vaccine that it plans to […]